Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04862312 · ClinicalTrials.gov registry record · NA

Video Chat During Meals to Improve Nutritional Intake in Older Adults

A NA study, sponsored by Cornell University.

Completed
Registry status
NA
Development phase
33
Enrollment target

NCT04862312: Completed NA study, sponsored by Cornell University.

NCT04862312 is a NA study that has completed, run by Cornell University. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04862312, a NA study, has completed, sponsored by Cornell University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target

Study Summary

The VideoDining study is a Stage IB behavioral intervention development project. The objectives are to determine the feasibility and acceptability of using video chat during mealtimes (VideoDining) in community-dwelling older adults eating alone at home and to evaluate changes in nutritional intake and loneliness in response to VideoDining.

Primary Outcome

A research interviewer will use video chat to collect three 24-hour dietary recalls with each participant prior to starting the VideoDining sessions (pre-VideoDining). During the intervention phase, a research interviewer will use video chat to collect a 24-hour dietary recall after each VideoDining session to capture dietary intake during the VideoDining meal and subsequent day (post-VideoDining). Change in dietary intake will be calculated by comparing average caloric intake on the three pre-V

Interventions

  • BEHAVIORAL VideoDine

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2021-03-31
Est. Completion 2022-05-17
Phase NA
Cornell University

66 total trials

What the finished NCT04862312 record still lists

NCT04862312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which VideoDine is the first listed.

NCT04862312 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04862312 about?

NCT04862312 is a clinical study titled "Video Chat During Meals to Improve Nutritional Intake in Older Adults". The VideoDining study is a Stage IB behavioral intervention development project. The objectives are to determine the feasibility and acceptability of using video chat during mealtimes (VideoDining) in community-dwelling older adults eating alone at home and to evaluate changes in nutritional intake ...

What is the current status of trial NCT04862312?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-03-31. Estimated completion is 2022-05-17.

What interventions are being tested in trial NCT04862312?

The interventions under investigation include: VideoDine (BEHAVIORAL).

Who is sponsoring clinical trial NCT04862312?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04862312's enrollment target sits among peer trials

33 1574th of 2000 higher than 423 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04862312, the US trial registry maintained by the National Library of Medicine. NCT04862312 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.